PortfoliosLab logoPortfoliosLab logo
VEON vs. UAMY
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

VEON vs. UAMY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in VEON Ltd. (VEON) and United States Antimony Corporation (UAMY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, VEON achieves a -4.07% return, which is significantly lower than UAMY's 55.38% return. Over the past 10 years, VEON has underperformed UAMY with an annualized return of -2.63%, while UAMY has yielded a comparatively higher 42.24% annualized return.


VEON

1D
-3.08%
1M
-10.60%
YTD
-4.07%
6M
-4.31%
1Y
26.07%
3Y*
38.19%
5Y*
3.00%
10Y*
-2.63%

UAMY

1D
-0.64%
1M
-7.36%
YTD
55.38%
6M
39.53%
1Y
185.71%
3Y*
192.90%
5Y*
52.68%
10Y*
42.24%
*Multi-year figures are annualized to reflect compound growth (CAGR)

VEON vs. UAMY - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
VEON
VEON Ltd.
-4.07%31.10%103.55%60.82%-71.35%13.25%-37.09%18.88%-34.17%5.59%
UAMY
United States Antimony Corporation
55.38%183.62%610.84%-48.86%-2.19%-4.64%35.58%-33.62%81.25%27.49%

Correlation

The correlation between VEON and UAMY is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.05

Correlation (3Y)
Calculated over the trailing 3-year period

0.03

Correlation (5Y)
Calculated over the trailing 5-year period

0.08

Correlation (10Y)
Calculated over the trailing 10-year period

0.08

Correlation (All Time)
Calculated using the full available price history since Feb 24, 2000

0.06

Fundamentals

Market Cap

VEON:

$3.60B

UAMY:

$1.10B

EPS

VEON:

$8.09

UAMY:

-$0.13

PS Ratio

VEON:

0.72

UAMY:

25.77

PB Ratio

VEON:

2.45

UAMY:

8.37

Total Revenue (TTM)

VEON:

$4.59B

UAMY:

$39.04M

Gross Profit (TTM)

VEON:

$3.63B

UAMY:

$4.34M

EBITDA (TTM)

VEON:

$1.69B

UAMY:

-$15.23M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

VEON vs. UAMY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VEON
VEON Risk / Return Rank: 5959
Overall Rank
VEON Sharpe Ratio Rank: 5959
Sharpe Ratio Rank
VEON Sortino Ratio Rank: 5858
Sortino Ratio Rank
VEON Omega Ratio Rank: 5757
Omega Ratio Rank
VEON Calmar Ratio Rank: 6060
Calmar Ratio Rank
VEON Martin Ratio Rank: 5959
Martin Ratio Rank

UAMY
UAMY Risk / Return Rank: 7979
Overall Rank
UAMY Sharpe Ratio Rank: 8181
Sharpe Ratio Rank
UAMY Sortino Ratio Rank: 8383
Sortino Ratio Rank
UAMY Omega Ratio Rank: 7777
Omega Ratio Rank
UAMY Calmar Ratio Rank: 8080
Calmar Ratio Rank
UAMY Martin Ratio Rank: 7373
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VEON vs. UAMY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for VEON Ltd. (VEON) and United States Antimony Corporation (UAMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


VEONUAMYDifference
Sharpe ratioReturn per unit of total volatility

-0.92

Sortino ratioReturn per unit of downside risk

-1.31

Omega ratioGain probability vs. loss probability

1.14

1.27

-0.13

Calmar ratioReturn relative to maximum drawdown

0.86

2.52

-1.66

Martin ratioReturn relative to average drawdown

1.64

4.26

-2.62

VEON vs. UAMY - Sharpe Ratio Comparison

The current VEON Sharpe Ratio is 0.50, which is lower than the UAMY Sharpe Ratio of 1.41. The chart below compares the historical Sharpe Ratios of VEON and UAMY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

VEON vs. UAMY - Drawdown Comparison

The maximum VEON drawdown since its inception was -98.74%, roughly equal to the maximum UAMY drawdown of -96.44%. Use the drawdown chart below to compare losses from any high point for VEON and UAMY.


Loading charts...

Drawdown Indicators


VEONUAMYDifference

Max Drawdown

Largest peak-to-trough decline

-98.74%

-96.44%

-2.30%

Max Drawdown (1Y)

Largest decline over 1 year

-30.54%

-74.30%

+43.76%

Max Drawdown (3Y)

Largest decline over 3 years

-32.15%

-74.30%

+42.15%

Max Drawdown (5Y)

Largest decline over 5 years

-88.66%

-80.46%

-8.20%

Max Drawdown (10Y)

Largest decline over 10 years

-92.52%

-89.76%

-2.76%

Current Drawdown

Current decline from peak

-90.35%

-55.35%

-35.00%

Average Drawdown

Average peak-to-trough decline

-62.64%

-66.40%

+3.76%

Ulcer Index

Depth and duration of drawdowns from previous peaks

15.94%

43.78%

-27.84%

Volatility

VEON vs. UAMY - Volatility Comparison

The current volatility for VEON Ltd. (VEON) is 10.18%, while United States Antimony Corporation (UAMY) has a volatility of 27.35%. This indicates that VEON experiences smaller price fluctuations and is considered to be less risky than UAMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


VEONUAMYDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.18%

27.35%

-17.17%

Volatility (6M)

Calculated over the trailing 6-month period

34.82%

92.15%

-57.33%

Volatility (1Y)

Calculated over the trailing 1-year period

52.89%

132.39%

-79.50%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

69.28%

95.17%

-25.89%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

55.97%

101.09%

-45.12%

Dividends

VEON vs. UAMY - Dividend Comparison

Neither VEON nor UAMY has paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
UAMY
United States Antimony Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
VEON
VEON Ltd.
0.00%0.00%0.00%0.00%0.00%0.00%7.62%9.58%9.47%5.97%0.68%0.80%

Financials

VEON vs. UAMY - Financials Comparison

This section allows you to compare key financial metrics between VEON Ltd. and United States Antimony Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50B2.00B20222023202420252026
1.21B
6.78M
(VEON) Total Revenue
(UAMY) Total Revenue
Values in USD except per share items

Frequently Asked Questions


VEON and UAMY have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

UAMY has higher volatility (27.35%) compared to VEON (10.18%). In terms of maximum drawdown, VEON dropped -98.74% vs UAMY's -96.44%.

UAMY currently has the higher Sharpe Ratio (1.41 vs 0.50), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for VEON and UAMY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer